Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Cytek Biosciences, Inc. (CTKB) had Operating Cash Flow per Share of $-0.02 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$44.13M |
|
$-18.87M |
|
$22.88M |
|
$21.25M |
|
$62.60M |
|
$-18.46M |
|
$1.09M |
|
$-17.37M |
|
$-17.37M |
|
$-18.87M |
|
$-18.87M |
|
$-18.87M |
|
$-18.87M |
|
$-18.46M |
|
$-15.65M |
|
128.70M |
|
128.70M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$379.30M |
|
$20.47M |
|
$69.81M |
|
$449.11M |
|
$80.94M |
|
$0.39M |
|
$40.53M |
|
$121.47M |
|
$327.64M |
|
$295.25M |
|
$327.64M |
|
129.14M |
|
| Cash Flow Statement Financials | |
$-2.74M |
|
$-27.08M |
|
$3.98M |
|
$90.85M |
|
$65.67M |
|
$-25.19M |
|
$4.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.69 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
48.16% |
|
-41.83% |
|
-41.83% |
|
-- |
|
-39.36% |
|
-42.75% |
|
$-4.90M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.46 |
|
0.85 |
|
105.84 |
|
-5.76% |
|
-6.39% |
|
-4.20% |
|
-5.75% |
|
$2.54 |
|
$-0.04 |
|
|
Operating Cash Flow per Share |
$-0.02 |